Skip to main content
PMC home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1985 Oct;62(1):1–12.

Eosinophils as effector cells in immunity and hypersensitivity disorders.

A B Kay
PMCID: PMC1577420  PMID: 3905092

Full text

PDF
4

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ackerman S. J., Kephart G. M., Habermann T. M., Greipp P. R., Gleich G. J. Localization of eosinophil granule major basic protein in human basophils. J Exp Med. 1983 Sep 1;158(3):946–961. doi: 10.1084/jem.158.3.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ackerman S. J., Weil G. J., Gleich G. J. Formation of Charcot-Leyden crystals by human basophils. J Exp Med. 1982 Jun 1;155(6):1597–1609. doi: 10.1084/jem.155.6.1597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Anwar A. R., Kay A. B. Membrane receptors for IgG and complement (C4, C3b and C3d) on human eosinophils and neutrophils and their relation to eosinophilia. J Immunol. 1977 Sep;119(3):976–982. [PubMed] [Google Scholar]
  4. Anwar A. R., Kay A. B. The ECF-A tetrapeptides and histamine selectively enhance human eosinophil complement receptors. Nature. 1977 Oct 6;269(5628):522–524. doi: 10.1038/269522a0. [DOI] [PubMed] [Google Scholar]
  5. Anwar A. R., McKean J. R., Smithers S. R., Kay A. B. Human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni in vitro. I. Enhancement of complement-dependent damage by mast cell-derived mediators and formyl methionyl peptides. J Immunol. 1980 Mar;124(3):1122–1129. [PubMed] [Google Scholar]
  6. Anwar A. R., Smithers S. R., Kay A. B. Killing of schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leukocytes in vitro: requirement for complement in preferential killing by eosinophils. J Immunol. 1979 Feb;122(2):628–637. [PubMed] [Google Scholar]
  7. BESSIS M., THIERY J. P. Electron microscopy of human white blood cells and their stem cells. Int Rev Cytol. 1961;12:199–241. doi: 10.1016/s0074-7696(08)60541-0. [DOI] [PubMed] [Google Scholar]
  8. Bass D. A., Grover W. H., Lewis J. C., Szejda P., DeChatelet L. R., McCall C. E. Comparison of human eosinophils from normals and patients with eosinophilia. J Clin Invest. 1980 Dec;66(6):1265–1273. doi: 10.1172/JCI109978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bass D. A., Szejda P. Mechanisms of killing of newborn larvae of Trichinella spiralis by neutrophils and eosinophils. Killing by generators of hydrogen peroxide in vitro. J Clin Invest. 1979 Dec;64(6):1558–1564. doi: 10.1172/JCI109616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Butterworth A. E., Richardson B. A. Factors affecting the levels of antibody- and complement-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni in vitro. Parasite Immunol. 1985 Mar;7(2):119–131. doi: 10.1111/j.1365-3024.1985.tb00064.x. [DOI] [PubMed] [Google Scholar]
  11. Butterworth A. E., Sturrock R. F., Houba V., Mahmoud A. A., Sher A., Rees P. H. Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature. 1975 Aug 28;256(5520):727–729. doi: 10.1038/256727a0. [DOI] [PubMed] [Google Scholar]
  12. Butterworth A. E., Vadas M. A., Wassom D. L., Dessein A., Hogan M., Sherry B., Gleich G. J., David J. R. Interactions between human eosinophils and schistosomula of Schistosoma mansoni. II. The mechanism of irreversible eosinophil adherence. J Exp Med. 1979 Dec 1;150(6):1456–1471. doi: 10.1084/jem.150.6.1456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Butterworth A. E., Wassom D. L., Gleich G. J., Loegering D. A., David J. R. Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J Immunol. 1979 Jan;122(1):221–229. [PubMed] [Google Scholar]
  14. Capron M., Bazin H., Joseph M., Capron A. Evidence for IgE-dependent cytotoxicity by rat eosinophils. J Immunol. 1981 May;126(5):1764–1768. [PubMed] [Google Scholar]
  15. Capron M., Capron A., Dessaint J. P., Torpier G., Johansson S. G., Prin L. Fc receptors for IgE on human and rat eosinophils. J Immunol. 1981 Jun;126(6):2087–2092. [PubMed] [Google Scholar]
  16. Capron M., Kusnierz J. P., Prin L., Spiegelberg H. L., Ovlaque G., Gosset P., Tonnel A. B., Capron A. Cytophilic IgE on human blood and tissue eosinophils: detection by flow microfluorometry. J Immunol. 1985 May;134(5):3013–3018. [PubMed] [Google Scholar]
  17. Capron M., Nogueira-Queiroz J. A., Papin J. P., Capron A. Interactions between eosinophils and antibodies: in vivo protective role against rat schistosomiasis. Cell Immunol. 1984 Jan;83(1):60–72. doi: 10.1016/0008-8749(84)90225-9. [DOI] [PubMed] [Google Scholar]
  18. Capron M., Rousseaux J., Mazingue C., Bazin H., Capron A. Rat mast cell-eosinophil interaction in antibody-dependent eosinophil cytotoxicity to Schistosoma mansoni schistosomula. J Immunol. 1978 Dec;121(6):2518–2525. [PubMed] [Google Scholar]
  19. Capron M., Spiegelberg H. L., Prin L., Bennich H., Butterworth A. E., Pierce R. J., Ouaissi M. A., Capron A. Role of IgE receptors in effector function of human eosinophils. J Immunol. 1984 Jan;132(1):462–468. [PubMed] [Google Scholar]
  20. Clark R. A., Gallin J. I., Kaplan A. P. The selective eosinophil chemotactic activity of histamine. J Exp Med. 1975 Dec 1;142(6):1462–1476. doi: 10.1084/jem.142.6.1462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. David J. R., Vadas M. A., Butterworth A. E., de Brito P. A., Carvalho E. M., David R. A., Bina J. C., Andrade Z. A. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med. 1980 Nov 13;303(20):1147–1152. doi: 10.1056/NEJM198011133032004. [DOI] [PubMed] [Google Scholar]
  22. Davis W. B., Fells G. A., Sun X. H., Gadek J. E., Venet A., Crystal R. G. Eosinophil-mediated injury to lung parenchymal cells and interstitial matrix. A possible role for eosinophils in chronic inflammatory disorders of the lower respiratory tract. J Clin Invest. 1984 Jul;74(1):269–278. doi: 10.1172/JCI111411. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. De Monchy J. G., Kauffman H. F., Venge P., Koëter G. H., Jansen H. M., Sluiter H. J., De Vries K. Bronchoalveolar eosinophilia during allergen-induced late asthmatic reactions. Am Rev Respir Dis. 1985 Mar;131(3):373–376. doi: 10.1164/arrd.1985.131.3.373. [DOI] [PubMed] [Google Scholar]
  24. De Simone C., Donelli G., Meli D., Molinari A., Rosati F., Sorice F. Human peripheral eosinophils with receptors for IgM: demonstration and ultrastructural morphology. Immunobiology. 1982;162(2):116–127. doi: 10.1016/S0171-2985(11)80023-9. [DOI] [PubMed] [Google Scholar]
  25. Dessein A. J., Parker W. L., James S. L., David J. R. IgE antibody and resistance to infection. I. Selective suppression of the IgE antibody response in rats diminishes the resistance and the eosinophil response to Trichinella spiralis infection. J Exp Med. 1981 Feb 1;153(2):423–436. doi: 10.1084/jem.153.2.423. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Dessein A. J., Vadas M. A., Nicola N. A., Metcalf D., David J. R. Enhancement of human blood eosinophil cytotoxicity by semi-purified eosinophil colony-stimulating factor(s). J Exp Med. 1982 Jul 1;156(1):90–103. doi: 10.1084/jem.156.1.90. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Diaz P., Galleguillos F. R., Gonzalez M. C., Pantin C. F., Kay A. B. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leukocyte counts, immunoglobulins, and complement. J Allergy Clin Immunol. 1984 Jul;74(1):41–48. doi: 10.1016/0091-6749(84)90085-x. [DOI] [PubMed] [Google Scholar]
  28. Durack D. T., Ackerman S. J., Loegering D. A., Gleich G. J. Purification of human eosinophil-derived neurotoxin. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5165–5169. doi: 10.1073/pnas.78.8.5165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Eosinophils and mediators of anaphylaxis. Histamine and imidazole acetic acid as chemotactic agents for human eosinophil leucocytes. Immunology. 1976 Nov;31(5):797–802. [PMC free article] [PubMed] [Google Scholar]
  30. Filley W. V., Holley K. E., Kephart G. M., Gleich G. J. Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma. Lancet. 1982 Jul 3;2(8288):11–16. doi: 10.1016/s0140-6736(82)91152-7. [DOI] [PubMed] [Google Scholar]
  31. Fischkoff S. A., Pollak A., Gleich G. J., Testa J. R., Misawa S., Reber T. J. Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60. J Exp Med. 1984 Jul 1;160(1):179–196. doi: 10.1084/jem.160.1.179. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Frigas E., Loegering D. A., Gleich G. J. Cytotoxic effects of the guinea pig eosinophil major basic protein on tracheal epithelium. Lab Invest. 1980 Jan;42(1):35–43. [PubMed] [Google Scholar]
  33. Goers J. W., Glovsky M. M., Hunkapiller M. W., Farnsworth V., Richards J. H. Studies on C3ahu binding to human eosinophils: characterization of binding. Int Arch Allergy Appl Immunol. 1984;74(2):147–151. doi: 10.1159/000233535. [DOI] [PubMed] [Google Scholar]
  34. Goetzl E. J., Austen K. F. Purification and synthesis of eosinophilotactic tetrapeptides of human lung tissue: identification as eosinophil chemotactic factor of anaphylaxis. Proc Natl Acad Sci U S A. 1975 Oct;72(10):4123–4127. doi: 10.1073/pnas.72.10.4123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Gosset P., Tonnel A. B., Joseph M., Prin L., Mallart A., Charon J., Capron A. Secretion of a chemotactic factor for neutrophils and eosinophils by alveolar macrophages from asthmatic patients. J Allergy Clin Immunol. 1984 Dec;74(6):827–834. doi: 10.1016/0091-6749(84)90186-6. [DOI] [PubMed] [Google Scholar]
  36. Griffin J. D., Meuer S. C., Schlossman S. F., Reinherz E. L. T cell regulation of myelopoiesis: analysis at a clonal level. J Immunol. 1984 Oct;133(4):1863–1868. [PubMed] [Google Scholar]
  37. Henderson W. R., Chi E. Y., Klebanoff S. J. Eosinophil peroxidase-induced mast cell secretion. J Exp Med. 1980 Aug 1;152(2):265–279. doi: 10.1084/jem.152.2.265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Henderson W. R., Jörg A., Klebanoff S. J. Eosinophil peroxidase-mediated inactivation of leukotrienes B4, C4, and D4. J Immunol. 1982 Jun;128(6):2609–2613. [PubMed] [Google Scholar]
  39. Horn B. R., Robin E. D., Theodore J., Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Med. 1975 May 29;292(22):1152–1155. doi: 10.1056/NEJM197505292922204. [DOI] [PubMed] [Google Scholar]
  40. Jörg A., Henderson W. R., Murphy R. C., Klebanoff S. J. Leukotriene generation by eosinophils. J Exp Med. 1982 Feb 1;155(2):390–402. doi: 10.1084/jem.155.2.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Kay A. B., Austen K. F. The IgE-mediated release of an eosinophil leukocyte chemotactic factor from human lung. J Immunol. 1971 Sep;107(3):899–902. [PubMed] [Google Scholar]
  42. Kay A. B. The role of the eosinophil. J Allergy Clin Immunol. 1979 Aug;64(2):90–104. doi: 10.1016/0091-6749(79)90042-3. [DOI] [PubMed] [Google Scholar]
  43. Kay A. B., Walsh G. M. Chemotactic factor-induced enhancement of the binding of human immunoglobulin classes and subclasses to neutrophils and eosinophils. Clin Exp Immunol. 1984 Sep;57(3):729–734. [PMC free article] [PubMed] [Google Scholar]
  44. Kazura J. W., Fanning M. M., Blumer J. L., Mahmoud A. A. Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest. 1981 Jan;67(1):93–102. doi: 10.1172/JCI110037. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Kojima S., Yamamoto N., Kanazawa T., Ovary Z. Monoclonal IgE-dependent eosinophil cytotoxicity to haptenated schistosomula of Schistosoma japonicum: enhancement of the cytotoxicity and expression of Fc receptors for IgE by Nippostrongylus brasiliensis infection. J Immunol. 1985 Apr;134(4):2719–2722. [PubMed] [Google Scholar]
  46. Kulczycki A., Jr Human neutrophils and eosinophils have structurally distinct Fc gamma receptors. J Immunol. 1984 Aug;133(2):849–854. [PubMed] [Google Scholar]
  47. Lee T., Lenihan D. J., Malone B., Roddy L. L., Wasserman S. I. Increased biosynthesis of platelet-activating factor in activated human eosinophils. J Biol Chem. 1984 May 10;259(9):5526–5530. [PubMed] [Google Scholar]
  48. McLaren D. J., Mackenzie C. D., Ramalho-Pinto F. J. Ultrastructural observations on the in vitro interaction between rat eosinophils and some parasitic helminths (Schistosoma mansoni, Trichinella spiralis and Nippostrongylus brasiliensis). Clin Exp Immunol. 1977 Oct;30(1):105–118. [PMC free article] [PubMed] [Google Scholar]
  49. McLaren D. J., McKean J. R., Olsson I., Venges P., Kay A. B. Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol. 1981 Winter;3(4):359–373. doi: 10.1111/j.1365-3024.1981.tb00414.x. [DOI] [PubMed] [Google Scholar]
  50. Moqbel R., MacDonald A. J., Kay A. B. Enhancement of human eosinophil- and neutrophil-mediated killing of schistosomula of Schistosoma mansoni by reversed type (IgE-mediated) anaphylaxis, in vitro. Clin Exp Immunol. 1985 Mar;59(3):577–586. [PMC free article] [PubMed] [Google Scholar]
  51. Moqbel R., Sass-Kuhn S. P., Goetzl E. J., Kay A. B. Enhancement of neutrophil- and eosinophil-mediated complement-dependent killing of schistosomula of Schistosoma mansoni in vitro by leukotriene B4. Clin Exp Immunol. 1983 Jun;52(3):519–527. [PMC free article] [PubMed] [Google Scholar]
  52. Nagy L., Lee T. H., Goetzl E. J., Pickett W. C., Kay A. B. Complement receptor enhancement and chemotaxis of human neutrophils and eosinophils by leukotrienes and other lipoxygenase products. Clin Exp Immunol. 1982 Mar;47(3):541–547. [PMC free article] [PubMed] [Google Scholar]
  53. Olsson I., Venge P. Cationic proteins of human granulocytes. II. Separation of the cationic proteins of the granules of leukemic myeloid cells. Blood. 1974 Aug;44(2):235–246. [PubMed] [Google Scholar]
  54. Parmley R. T., Spicer S. S. Cytochemical and ultrastructural identification of a small type granule in human late eosinophils. Lab Invest. 1974 May;30(5):557–567. [PubMed] [Google Scholar]
  55. Pincus S. H., Butterworth A. E., David J. R., Robbins M., Vadas M. A. Antibody-dependent eosinophil-mediated damage to schistosomula of Schistosoma mansoni: lack of requirement for oxidative metabolism. J Immunol. 1981 May;126(5):1794–1799. [PubMed] [Google Scholar]
  56. Presentey B., Szapiro L. Hereditary deficiency of peroxidase and phospholipids in eosinophilic granulocytes. Acta Haematol. 1969;41(6):359–362. doi: 10.1159/000208873. [DOI] [PubMed] [Google Scholar]
  57. Prin L., Charon J., Capron M., Gosset P., Taelman H., Tonnel A. B., Capron A. Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density. Clin Exp Immunol. 1984 Sep;57(3):735–742. [PMC free article] [PubMed] [Google Scholar]
  58. Ruscetti F. W., Cypess R. H., Chervenick P. A. Specific release of neutrophillic- and eosinophilic-stimulating factors from sensitized lymphocytes. Blood. 1976 May;47(5):757–765. [PubMed] [Google Scholar]
  59. Shaw R. J., Cromwell O., Kay A. B. Preferential generation of leukotriene C4 by human eosinophils. Clin Exp Immunol. 1984 Jun;56(3):716–722. [PMC free article] [PubMed] [Google Scholar]
  60. Shaw R. J., Walsh G. M., Cromwell O., Moqbel R., Spry C. J., Kay A. B. Activated human eosinophils generate SRS-A leukotrienes following IgG-dependent stimulation. Nature. 1985 Jul 11;316(6024):150–152. doi: 10.1038/316150a0. [DOI] [PubMed] [Google Scholar]
  61. Sher A. Complement-dependent adherence of mast cells to schistosomula. Nature. 1976 Sep 23;263(5575):334–336. doi: 10.1038/263334a0. [DOI] [PubMed] [Google Scholar]
  62. Tai P. C., Bakes D. M., Barkans J. R., Spry C. J. Plasma membrane antigens on light density and activated human blood eosinophils. Clin Exp Immunol. 1985 May;60(2):427–436. [PMC free article] [PubMed] [Google Scholar]
  63. Tai P. C., Spry C. J., Peterson C., Venge P., Olsson I. Monoclonal antibodies distinguish between storage and secreted forms of eosinophil cationic protein. Nature. 1984 May 10;309(5964):182–184. doi: 10.1038/309182a0. [DOI] [PubMed] [Google Scholar]
  64. Tai P. C., Spry C. J. Studies on blood eosinophils. I. Patients with a transient eosinophilia. Clin Exp Immunol. 1976 Jun;24(3):415–422. [PMC free article] [PubMed] [Google Scholar]
  65. Thorne K. J., Franks D. Surface proteins of the human eosinophil. I. Isolation of eosinophil IgG binding proteins. Clin Exp Immunol. 1984 May;56(2):464–472. [PMC free article] [PubMed] [Google Scholar]
  66. Turk J., Maas R. L., Brash A. R., Roberts L. J., 2nd, Oates J. A. Arachidonic acid 15-lipoxygenase products from human eosinophils. J Biol Chem. 1982 Jun 25;257(12):7068–7076. [PubMed] [Google Scholar]
  67. Vadas M. A. Cyclophosphamide pretreatment induces eosinophilia to nonparasite antigens. J Immunol. 1981 Nov;127(5):2083–2086. [PubMed] [Google Scholar]
  68. Veith M. C., Butterworth A. E. Enhancement of human eosinophil-mediated killing of Schistosoma mansoni larvae by mononuclear cell products in vitro. J Exp Med. 1983 Jun 1;157(6):1828–1843. doi: 10.1084/jem.157.6.1828. [DOI] [PMC free article] [PubMed] [Google Scholar]
  69. Weller P. F. Eosinophilia. J Allergy Clin Immunol. 1984 Jan;73(1 Pt 1):1–14. doi: 10.1016/0091-6749(84)90474-3. [DOI] [PubMed] [Google Scholar]
  70. Weller P. F., Goetzl E. J., Austen K. F. Identification of human eosinophil lysophospholipase as the constituent of Charcot-Leyden crystals. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7440–7443. doi: 10.1073/pnas.77.12.7440. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Weller P. F., Lee C. W., Foster D. W., Corey E. J., Austen K. F., Lewis R. A. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4. Proc Natl Acad Sci U S A. 1983 Dec;80(24):7626–7630. doi: 10.1073/pnas.80.24.7626. [DOI] [PMC free article] [PubMed] [Google Scholar]
  72. Winqvist I., Olofsson T., Olsson I., Persson A. M., Hallberg T. Altered density, metabolism and surface receptors of eosinophils in eosinophilia. Immunology. 1982 Nov;47(3):531–539. [PMC free article] [PubMed] [Google Scholar]
  73. Zheutlin L. M., Ackerman S. J., Gleich G. J., Thomas L. L. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J Immunol. 1984 Oct;133(4):2180–2185. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES